PeterLabs Holdings Berhad (KLSE:PLABS)
Malaysia · Delayed Price · Currency is MYR 0.2250
+0.0050 (2.27%)
At close: Sep 14, 2026
PeterLabs Holdings Berhad Revenue
In the fiscal year ending June 30, 2026, PeterLabs Holdings Berhad had annual revenue of 107.66M MYR, down -33.32%. PeterLabs Holdings Berhad had revenue of 17.00M in the quarter ending June 30, 2026, a decrease of -46.49%.
Revenue
107.66M
Revenue Growth
-33.32%
P/S Ratio
0.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 107.66M | -53.81M | -33.32% |
| Jun 30, 2025 | 161.47M | -14.56M | -8.27% |
| Dec 31, 2024 | 176.03M | -10.18M | -5.47% |
| Dec 31, 2023 | 186.21M | 24.58M | 15.20% |
| Dec 31, 2022 | 161.63M | -22.19M | -12.07% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DXN Holdings Bhd. | 1.89B |
| Duopharma Biotech Berhad | 929.41M |
| Y.S.P. Southeast Asia Holding Berhad | 369.53M |
| Kotra Industries Berhad | 233.02M |
| Rhone Ma Holdings Berhad | 228.88M |
| Sunzen Group Berhad | 93.51M |
| Nova Wellness Group Berhad | 49.22M |
| Bioalpha Holdings Berhad | 10.93M |